Delivery Order SPE2DB22D3004-SPE2DB25FNY73

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication, with a firm fixed price ceiling value of $1,467.09 and an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,694.70, is for the delivery of REPATHA 140 MG/ML SURECLICK ML, a specialty medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is October 22, 2024. The contract is not designated with a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,016.82, is for the delivery of REPATHA 140 MG/ML SURECLICK, a specialty medication. The contract has an ultimate completion date of August 29, 2024 and is a firm fixed-price delivery order. The prime contractor, AmerisourceBergen Drug Corp, is a for-profit organization registered in the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of REPATHA 140 MG/ML SURECLICK medication, a specialty pharmaceutical product. The firm fixed price contract has a potential value of $1,016.84 and a performance period through February 7, 2024. Amerisourcebergen Drug Corp serves as the prime...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,207.92 firm fixed-price contract is for the supply of REPATHA 140 MG/ML SURECLICK medication. It is not designated as a set-aside contract. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $5,469.05 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of REPATHA 140 MG/ML SURECLICK® medication, with a performance period through March 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of REPATHA 140 MG/ML SURECLICKML, a specialty medication, with a ceiling value of $14,526.30. The contract is a firm fixed-price Delivery Order with a completion date of December 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,262.07 Delivery Order contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty cardiovascular medication. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product REPATHA 140 MG/ML SURECLICK. The contract has a completion date of January 30, 2024 and a potential value of $1,525.23. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of...
This is a $3,847.39 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of REPATHA 140 MG/ML SURECLICK syringes. The order has an ultimate completion date of August 8, 2024. AmerisourceBergen, as a major pharmaceutical distributor, supports federal healthcare programs and agencies through various contract vehicles, including an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 for...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FNY73
    Delivery Order

This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The $2,629.95 firm fixed-price contract has an ultimate completion date of December 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not include any set-aside designations, indicating open competition.

Generated 3/31/25, 9:40 AM